United Biotech has been a trend setter of new standards and is among the fastest growing companies in the Indian pharmaceutical Industry.

Headquartered in Mumbai India, GenPharma is with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Everyday, they strive to discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of functioning.

About Author: Jadhav Ramulu 1, P. Goverdhan2
1 Vaagdevi College of Pharmacy, Hanamkonda-Warangal (Affiliated to Kakatiya University), A.P-506002, INDIA
2 Head of the department, pharmacology, Vaagdevi College of Pharmacy, Hanamkonda-Warangal, A.P-506002, INDIA

Abstract
Computer aided drug design(CADD) is an emerging tool for research and drug development process as it reduce the time taken for the process of drug development and expense. Several new technologies have been developed and applied in drug R & D to shorten the research cycle and to reduce the expenses. In computer aided drug design process so many computational tools are used such as over viewing tools, homology modeling, and homology modeling programs, molecular dynamics, molecular docking and QSAR descriptors. This article provides a brief idea on computer aided drug design process and list of software used.

Headquartered in Mumbai India, GenPharma is with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Everyday, they strive to discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of functioning.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Celestial Biolabs Ltd is an ISO 9001-2001 certified listed company with NSE and BSE company ,Celestial has been providing customized IT solutions for Pharma, Bio-pharma, Biotech and manufacturing, Now Expanding business in Pharma Exports.

Symbiotec Pharmalab Ltd., a cortico-steroids API manufacturing company based at Indore in Central India is in the business of development, production and marketing of research-based cortico steroids.

Institute of Liver and Biliary Sciences (ILBS) has been set up as an autonomous super specialty Institute of excellence under GNCT of Delhi. Its vision is to be a global leader by becoming a beacon of patient care, teaching and research in the field of adult and pediatric Liver and Biliary Diseases.

Applications in the prescribed forms are invited for direct recruitment to the following posts by 29th September 2011 (7th October 2011 in respect of applications received only BY POST from the candidates residing in Assam, Meghalaya, Arunachal Pradesh, Mizoram, Manipur, Nagaland, Tripura, Sikkim, J&K, Lahaul & Spiti District and Pangi Sub-division of Chamba district of Himachal Pradesh, A & N Islands or Lakshadweep or abroad).

I.I.T. Delhi is an autonomous statutory organisation functioning within the “Institutes of Technology Act” as amended by “The Institutes of Technology (Amendment) Act, 1963″.

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies.

About Author: Uday Venkat Mateti^1*, Srikala Patha²
1. Department of Pharmacy Practice  & Pharm.D, St Peter’s Institute of Pharmaceutical Sciences, Rohini Hospital, Kakatiya University, Warangal, India
2. Department of Pharmacy Practice, Bharat Institute of Technology (Pharmacy), KIMS Hospital, JNTU, Hyderabad, India

Abstract
The mortality rate of febrile neutropenia (FN) has diminished steadily but remains significant. Overall mortality rates are 5% in patients with solid tumors (1% in low-risk patients) and as high as 11% in some hematological malignancies. Piperacillin/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad spectrum of antibacterial activity against most Gram-positive, Gram-negative aerobic bacteria and anaerobic bacteria. Piperacillin/Tazobactam is effective and well tolerated in patients with febrile neutropenia.  Guidelines for the Management of Febrile Neutropenia in Oncology Patients and the 2010 National Comprehensive Cancer Network (NCCN) Prevention and treatment  for febrile neutropenia recommends as initial treatment in patients with FN who are at high risk of serious infections. In comparative clinical trials against various other antibacterial regimens. Piperacillin/Tazobactam has shown higher clinical success rates, particularly in the treatment of patients with febrile neutropenia. Piperacillin/Tazobactam has shown clinical as well as the economic advantages over other antibacterial regimens in the treatment of febrile episodes in patients with neutropenia. It is likely to reduce overall treatment costs of moderate to severe febrile neutropenia by increasing initial treatment success thereby reducing the length of hospital stay and the use of additional antibacterials. Present data regarding clinical efficacy, safety and costs would support the use of Piperacillin/Tazobactam as an empirical first-line option in moderate to severe febrile episodes in patients with neutropenia.

The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine.

The National Centre for Cell Science (NCCS) took birth as National Tissue Culture Facility in March 11, 1986 with a mandate of basic research, teaching & training, and as a national repository for cell lines/hybridomas etc.  The centre is located in the midst of academically enriched environment of University of Pune campus, Pune.